SuperworthSerina Therapeutics shares outstanding SER
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 16.4M
- On a year earlier
- +63.8%
- more shares
Serina Therapeutics had 16.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 63.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 10.7M | +17% |
| FY2024 | 9.1M | +744% |
| FY2023 | 1.1M | −0% |
| FY2022 | 1.1M | −97% |
| FY2021 | 37.9M | +1% |
| FY2020 | 37.7M | +0% |
| FY2019 | 37.7M | +5% |
| FY2018 | 35.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 16.4M | +64% | |
| Q1 FY26 | 12M | +23% | |
| Q4 FY25 | 10.7M | +17% | |
| Q3 FY25 | 10.3M | −4% | |
| Q2 FY25 | 10M | −2% | |
| Q1 FY25 | 9.8M | +250% | |
| Q4 FY24 | 9.1M | +744% | |
| Q3 FY24 | 10.8M | +42% | |
| Q2 FY24 | 10.2M | +37% | |
| Q1 FY24 | 2.8M | −67% | |
| Q4 FY23 | 1.1M | −0% | |
| Q3 FY23 | 7.6M | −80% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Serina Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.